Swiss Paediatric Oncology Group

Recent papers from Swiss Paediatric Oncology Group

1. Shortages of paediatric primary care and contributing factors in Switzerland: a nationwide paediatrician survey and cross-sectional workforce analysisSwiss Medical Weekly · 2026
2. Correction: Bignotti et al. Class II Malocclusion Correction Using “Distalizing Bar Appliances” and Clear Aligners: A Case Series and Clinical Technique. Dent. J. 2026, 14, 334Dentistry Journal · 2026
3. On-label paediatric drug product information in Switzerland – the neglected childEuropean Journal of Hospital Pharmacy · 2026
4. Survival after breast-conserving surgery and radiotherapy versus mastectomy: a propensity score-matched analysis within a randomized anaesthesiology trialBritish journal of surgery · 2026
5. β-Lactam vs Non–β-Lactam Antimicrobial Prophylaxis and Surgical Site InfectionJAMA Network Open · 2025
6. A retrospective analysis of phase I and phase I/II investigator-initiated clinical trials conducted by the Swiss Group for Clinical Cancer Research (SAKK)ESMO Open · 2025
7. The planetary diet: a nutritional utopia in conflict with human evolutionNutrition & Metabolism · 2025
8. Uterine mesenchymal tumour with a novel EWSR1::CTBP1 gene fusionVirchows Archiv · 2025
9. Expert consensus for prevention, diagnosis and management of persistent chemotherapy-induced alopecia.2025
10. Effectiveness and safety of first-line empirical Helicobacter pylori eradication regimens in Switzerland: an interim analysis from a prospective multicentre registry (Hp-EuReg)Schweizerische medizinische Wochenschrift · 2025
11. Acute flaccid myelitis in Europe between 2016 and 2023: indicating the need for better registrationEurosurveillance · 2025
12. Safety and tolerability of intravenous liposomal GM1 in patients with Parkinson disease: A single-center open-label clinical phase I trial (NEON trial)PLoS Medicine · 2025
13. AI-powered evaluation of lung function for diagnosis of interstitial lung diseaseThorax · 2025
14. CITRINO: phase 1 dose escalation study of anti-LAG-3 antibody encelimab alone or in combination with anti-PD-1 dostarlimab in patients with advanced/metastatic solid tumoursBJC Reports · 2025
15. Mapping healthcare services and practice variations in spinal care across countries: The Spine Atlas InitiativeBrain and Spine · 2025
16. Paediatric Personalized Research Network Switzerland (SwissPedHealth): a joint paediatric national data streamBMJ Open · 2024
17. Multiple myeloma refractory to lenalidomide: A systematic literature review of trials and real‐world evidenceBritish Journal of Haematology · 2024
18. The impact of patients' pre‐treatment expectations on immunosuppressive treatment outcomes in myasthenia gravis: A pilot correlational studyMuscle & Nerve · 2024
19. Telemedicine in Nail Psoriasis: Validation of a New Tool to Monitor (In-Person, In-Picture, and In-Video) Nail Psoriasis Severity in Patients with Concurrent Onychophagia and OnychotillomaniaDermatology and Therapy · 2024
20. Impact of Helicobacter pylori and metabolic syndrome-related mast cell activation on cardiovascular diseasesFrontiers in Gastroenterology · 2024